Literature DB >> 12055261

IFN-gamma-inducible T cell alpha chemoattractant is a potent stimulator of normal human blood T lymphocyte transendothelial migration: differential regulation by IFN-gamma and TNF-alpha.

Karkada Mohan1, Ziqiang Ding, John Hanly, Thomas B Issekutz.   

Abstract

Previous studies have shown that the CXC chemokine, IFN-gamma-inducible T cell alpha chemoattractant (I-TAC), was chemotactic for IL-2-activated human T lymphocytes, which express abundant CXCR3. However, because most memory T lymphocytes are also CXCR3(+), the ability of I-TAC to promote the migration of normal human blood T cells across HUVEC monolayers in Transwell chambers was examined. I-TAC induced a marked (4- to 6-fold) increase in transendothelial migration (TEM) of T cells across unstimulated HUVEC from 5.6 to 28% of input T cells and was substantially more active than IFN-gamma-inducible protein-10, another CXCR3 ligand. I-TAC significantly enhanced TEM of T cells across TNF-alpha, but not across IFN-gamma or IFN-gamma plus TNF-alpha-activated HUVEC. IFN-gamma or IFN-gamma plus TNF-alpha-activated HUVEC produced substantial amounts of I-TAC, in contrast to TNF-alpha-treated EC. Both CD4(+) and CD8(+) T cells migrated in response to I-TAC to a similar extent, while memory T cells migrated several fold better than naive T cells. Blockade of LFA-1 strongly inhibited I-TAC-induced T cell TEM across unstimulated HUVEC, and approximately 50-60% of the TEM across cytokine-activated HUVEC. However, blocking both LFA-1 and very late Ag-4 abolished I-TAC induced T cell TEM. In vivo significant levels of I-TAC were detected in arthritic synovial fluid. Thus, I-TAC is one of the most potent chemoattractants of normal human blood CD4 and CD8 T cell TEM and is likely a major mediator of blood memory T lymphocyte migration to inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055261     DOI: 10.4049/jimmunol.168.12.6420

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  TNF-α and IFN-γ promote lymphocyte adhesion to endothelial junctional regions facilitating transendothelial migration.

Authors:  Justyna Jaczewska; Midhat H Abdulreda; Chi Y Yau; Martin M Schmitt; Irene Schubert; Per-Olof Berggren; Christian Weber; Rory R Koenen; Vincent T Moy; Ewa P Wojcikiewicz
Journal:  J Leukoc Biol       Date:  2013-09-26       Impact factor: 4.962

2.  CXCR6 is expressed on T cells in both T helper type 1 (Th1) inflammation and allergen-induced Th2 lung inflammation but is only a weak mediator of chemotaxis.

Authors:  Markus Latta; Karkada Mohan; Thomas B Issekutz
Journal:  Immunology       Date:  2007-04-16       Impact factor: 7.397

3.  Rat chemokine CXCL11: structure, tissue distribution, function and expression in cardiac transplantation models.

Authors:  Noboru Mitsuhashi; Gordon D Wu; Hui Zhu; Mary Kearns-Jonker; Donald V Cramer; Vaughn A Starnes; Mark L Barr
Journal:  Mol Cell Biochem       Date:  2007-01-31       Impact factor: 3.396

Review 4.  Chemokines in joint disease: the key to inflammation?

Authors:  J J Haringman; J Ludikhuize; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

5.  CXCL11 is involved in leucocyte recruitment to the central nervous system in neuroborreliosis.

Authors:  Tobias A Rupprecht; Uwe Koedel; Beatrice Muhlberger; Bettina Wilske; Adriano Fontana; Hans-Walter Pfister
Journal:  J Neurol       Date:  2005-03-06       Impact factor: 4.849

6.  Polarized localization of epithelial CXCL11 in chronic obstructive pulmonary disease and mechanisms of T cell egression.

Authors:  Joanna C Porter; Mary Falzon; Alan Hall
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

7.  The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis.

Authors:  Akiko Ueno; Masahiro Yamamura; Mitsuhiro Iwahashi; Akira Okamoto; Tetsushi Aita; Norio Ogawa; Hirofumi Makino
Journal:  Rheumatol Int       Date:  2004-03-05       Impact factor: 2.631

Review 8.  Therapy for chronic obstructive pulmonary disease in the 21st century.

Authors:  Louise E Donnelly; Duncan F Rogers
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection.

Authors:  J Christian J Ray; JoAnne L Flynn; Denise E Kirschner
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

Review 10.  Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Andrea T Borchers; Shinji Shimoda; Christopher Bowlus; Carl L Keen; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.